The study by Zeiter et al. examined the expression of L1CAM in 212 patients and found positivity in 19.3% of the cases with the cutoff value of 10%, but without any association with lymph node metastasis [54]. Here, L1CAM is linked to metastatic malignant neoplasm in the lymph nodes.